<!doctype html>

<meta charset="utf-8">

<title>
  KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity
</title>

<link rel="stylesheet" href="style.css">

<header>

  <nav>

    <ul>

      <li>
        <a href="./">Home</a>
      </li>

    </ul>

  </nav>

</header>

<main>

  <article>

    <header>

      <ol>
        <li aria-label="Article category">
          Cell Biology
        </li>
        <li aria-label="Article type">
          New Results
        </li>
      </ol>

      <h1>
        KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity
      </h1>

      <ol aria-label="Authors of this article">
        <li>
          Marjorie Fournier
        </li>
        <li>
          Jean-Yves Bleuyard
        </li>
        <li>
          Anthony M. Couturier
        </li>
        <li>
          Jessica Ellins
        </li>
        <li>
          Svenja Hester
        </li>
        <li>
          Stephen J. Smerdon
        </li>
        <li>
          László Tora
        </li>
        <li>
          Fumiko Esashi
        </li>
      </ol>

      <ul aria-label="Publication details">
        <li>
          DOI: <a href="https://doi.org/10.1101/735811">10.1101/735811</a>
        </li>
        <li>
          Updated <time datetime="2020-01-21">Jan 21, 2020</time>
        </li>
      </ul>

    </header>

    <section role="doc-abstract">

      <h2>
        Abstract
      </h2>

      <p>
        The tumour suppressor PALB2 stimulates error-free repair of DNA breaks, whilst its steady-state chromatin
        association protects active genes from genotoxic stress. Here, we report that the lysine acetyltransferases 2A
        and 2B (KAT2A/B), commonly known to promote transcriptional activation, acetylate the PALB2 chromatin
        association motif (ChAM), providing a dynamic regulatory mechanism for PALB2. ChAM acetylation within a cluster
        of seven lysine residues (7K), detected in the chromatin-enriched fraction in undamaged cells, enhanced its
        association with nucleosomes while decreasing its non-specific binding to naked DNA. DNA damage triggered a
        rapid deacetylation of ChAM and a concomitant increase in PALB2 mobility. Significantly, a 7K-null mutation,
        which hindered ChAM binding to both nucleosomes and DNA, conferred deficiency in DNA repair and hypersensitivity
        to the anti-cancer drug olaparib. Thus, our study reveals a unique mechanism mediated by KAT2A/B-dependent
        acetylation of a non-histone protein, which fine-tunes the DNA damage response and hence promotes genome
        stability.
      </p>

    </section>

  </article>

</main>
